The rate of innovation is impressive both in terms of the opportunities it offers, and in terms of the complexity with which strategic decisions have to be made.
Discover how Predictive Clinical Intelligence, AI, and real-time analytics are transforming clinical drug research, drug development clinical trial phases, and the phases of drug development to help pharmaceutical companies make faster, smarter decisions.
It's the structured path a molecule follows from lab to market: preclinical research, Phase I (safety), Phase II (efficacy and dosing), Phase III (large-scale confirmation), regulatory review, and Phase IV post-market monitoring. As of 2026, nearly half of the roughly 23,000 active global pipeline drugs are still in the preclinical stage alone.
Discover how AI, real-time API intelligence, phases of pharmaceutical development, and API clinical trial data are transforming pharmaceutical supply chains through smarter forecasting, risk management, and strategic decision-making.
Learn how predictive supplier insights help prevent API shortages by identifying risks early, improving sourcing decisions, and ensuring supply continuity.
Here is a number that should stop you: more than 10,000 rare diseases have been identified globally, yet fewer than 500 have an approved treatment.
This is why more pharmaceutical companies are investing in unified intelligence platforms that centralize data, improve visibility, and support better decision-making across the drug development lifecycle.
Discover how early-phase pipeline tracking helps pharmaceutical companies identify high-value licensing opportunities, assess risks, and gain competitive advantage.
Backed by latest FDA data, this article analyzes approval trends, clinical challenges, and innovation drivers in pharmaceutical R&D.
Oncology is printing money. There is no other therapy area in global pharma that even comes close to the numbers being put up by cancer drugs right now.
29 September 2026
23 September 2026
21 September 2026
15 September 2026
1 September 2026
